Fhit expression is absent or reduced in a subset of primary head and neck cancer

Anticancer Research

Volumn 20, Issue 2 A, 2000, Pages 1057-1060

  Götte, Karl ^a   Hadaczek, Piotr ^b   Coy, Johannes F ^c   Wirtz, Heiner W ^a   Riedel, Frank ^a   Neubauer, Julia ^a   Hörmann, Karl ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

FHIT gene; Head and neck cancer; Immunohistochemistry; Loss of heterozygosity; Tumour suppressor gene

Indexed keywords

DNA; FRAGILE HISTIDINE TRIAD PROTEIN; POLYCLONAL ANTIBODY; RNA;

ARTICLE; CANCER GENETICS; CHROMOSOME 3P; CLINICAL ARTICLE; DELETION MUTANT; HEAD AND NECK CANCER; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; ANTIBODIES; CARCINOMA, SQUAMOUS CELL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; CYTOPLASM; DNA MUTATIONAL ANALYSIS; EXONS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEINS;

EID: 0344002715     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Parkin DM, Laara E and Muir CS: Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41: 184-197, 1988.
2. Ah-See KW, Cooke TG, Pickford IR, Soutar D and Balmain A: An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 54: 1617-1621, 1994.
3. Field JK, Kiaris H, Risk JM, Tsiriyotis C, Adamson R, Zoumpourlis V, Rowley H. Taylor K, Whittaker J. Howard P, Beirne JC, Gosney JR, Woolgar J, Vaughan ED, Spandidos DA and Jones AS: Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Br J Cancer 72: 1180-1118, 1995.
4. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM and Sidransky D: Allelotype of head and neck squamous cell carcinoma. Cancer Res 54: 1152-1155, 1994.
5. Reed AL, Califano J, Cairns P, Westra Wh, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J and Sidransky D: High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma Cancer Res 56: 3630-3633, 1996.
6. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, Correo R, Eby YJ, Ruppert JM and Sidransky D: The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 53: 4477-4480, 1993.
7. Erber R, Conradt C, Homann N, Enders C, Finckh M, Dietz A, Weidauer H and Bosch FX: TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Oncogene 16: 1671-1679, 1988.
8. Ishwad CS, Ferrell RE, Rossie KM, Appel BN, Johnson JT, Myers EN, Law JC, Srivastave S and Gollin SM: Loss of heterozygosity of the short arm of chromosome 3 and 9 in oral cancer. Int J Cancer 69: 1-4, 1996.
9. Maestro R, Gasparotto D, Vukosavljevic T, Barzan L, Sufaro S and Boiocchi M: Three discrete regions of deletion at 3p in head and neck cancer. Cancer Res 53: 5775-5779, 1993.
10. Wu CL, Sloan P, Read AP, Harris R and Thakker N: Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res 54: 6484-6488, 1994.
11. Glover TW, Coyle-Morris JF, Brown RS, Berger CS, Gemmill RM and Hecht F: Translocation t(3;8)(p14.2;q24) in renal cell carcinoma affects expression of the common fragile site at 3p14 (FRA3B) in lymphocytes. Cancer Genet Cytogenet 31: 69-73, 1988.
12. Ohta M, Inoue H, Cotticelli G, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM and Huebner K: The FHIT Gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587-597, 1996.
13. Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM and Pilotti S: Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 58: 5032-5037, 1998.
14. Tomizawa Y, Nakajima T, Kohno T, Saito R, Yamaguchi N and Yokota J: Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma. Cancer Res 58: 5478-5483, 1998.
15. Hadaczek P, Siprashvili Z, Markiewski M, Domagala W, Druck T, McCue PA, Pekarsky Y, Ohta M, Huebner K and Lubinski J: Absence or reduction of Fhit expression in most clear cell renal carcinomas. Cancer Res 58: 2946-2951, 1998.
16. Baffa R, Veronese LM, Santoro R, Mandes B, Palazzo JP, Rugge M, Santoro E, Croce CM and Huebner K: Loss of FHIT expression in gastric carcinoma. Cancer Res 58: 4708-4714, 1998.
17. Sorio C, Baron A, Orlandini S, Zamboni G, Pederzoli P, Huebner K and Scarpa A: The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers. Cancer Res 59: 1308-1314, 1999.
18. Nakagawa S, Yoshikawa H, Kimura M, Kawana K, Matsumoto K, Onda T, Kino N, Yamada M, Yasugi T and Taketani Y: A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix. Br J Cancer 79: 589-594, 1999.
19. Kisielewski AE, Xiao GH, Liu SC, Klein-Szanto AJ, Novara M, Sina J, Bleicher K, Yeung RS and Goodrow TL: Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck. Oncogene 17: 83-91, 1998.
20. Mao L, Fan Y-H, Lotan R and Hong WK: Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cacner cell lines. Cancer Res 56: 5128-5131, 1996.
21. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K and Croce CM: FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci U.S.A. 93: 9770-9775, 1996.
22. Bugert P. Wilhelm M and Kovacs G: FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Genes Chromosomes Cancer 20: 9-15, 1997.
23. Panagopoulos I, Thelin S, Mertens F, Mitelman F and Aman P: Variable FHIT transcripts in non-neoplastic tissues. Genes Chromosomes Cancer 19: 215-9, 1997.